 Home > Active Ingredient News > Digestive System Information > Teyi Pharmaceutical Metronidazole Tablets and Clindamycin Hydrochloride Capsules Passed the Consistency Evaluation

Teyi Pharmaceutical Metronidazole Tablets and Clindamycin Hydrochloride Capsules Passed the Consistency Evaluation

 Last Update: 2021-06-12
 Source: Internet
 Author: User

Tags

pylori bacteria infection

1 2 liter

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Teyi Pharmaceuticals issued an announcement stating that the company had recently obtained the "Metronidazole Tablets" and "Clindamycin Hydrochloride Capsules" "Drug Supplementary Application Approval Notice" approved and issued by the National Medical Products Administration.

Drug-related information:

(1) Metronidazole tablets are used to treat and prevent infections identified or suspected to be caused by anaerobic bacteria.

(2) Clindamycin Hydrochloride Capsules are mainly used for infectious diseases caused by sensitive strains such as Streptococcus, Staphylococcus and anaerobic bacteria, and are widely used clinically in the lower respiratory tract, skin, soft tissue, obstetrics and gynecology, and abdominal cavity Wait for infection.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.